AD & ALS Treatment Pipeline

Phenogene-1 combines two small molecules to treat neurodegenerative diseases, such as AD and ALS. 

 Phenogene-1a binds to amyloid-beta peptides to prevent their polymerization, interfere with amyloid plaque formation, and prevent the neurotoxic cascade that promotes neuronal death by inhibiting proinflammatory cytokines, microglia macrophage activation, suppressing fibrosis, and allowing neurite Growth.

Phenogene-1b is an anti-inflammatory NSAID that suppresses the inflammation associated with neurodegenerative advanced progress.